Tapering Multiple Benzodiazepine Drugs study through investigating Cognition and Risk of Side Effects for Depressio
Not Applicable
- Conditions
- depression
- Registration Number
- JPRN-UMIN000026499
- Lead Sponsor
- Kansai medical university
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 80
Inclusion Criteria
Not provided
Exclusion Criteria
Patients who contract disease affecting cognitive disfunction, for example epilepsy, alcohol dependence syndrome and so on. Pregnant patients.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method .Nerurocognitive battery
- Secondary Outcome Measures
Name Time Method .Cognitive Failures Questionnaire .Hamilton depression scale .Athens insomnia scale .State-Trait Anxiety Inventory .Social Adaptation Self-evaluation Scale .the clinical withdrawal assessment scale for benzodiazepines